
Depression among people diagnosed with multiple sclerosis (MS) has been estimated to be about three times more common than in...
Read More

Depression that doesn’t respond to conventional treatments is a serious problem for all who are affected, and poses unique risks...
Read More

On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach...
Read More

The last decade has seen a vast increase in the use of brain stimulation technologies to reduce symptoms of psychiatric...
Read More

By studying 129 people who were daily cigarette smokers and addicted to nicotine at the time they suffered brain damage,...
Read More